A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Pfizer
Pfizer
Tizona Therapeutics, Inc
C4 Therapeutics, Inc.
Immodulon Therapeutics Ltd
GlaxoSmithKline
Eli Lilly and Company
Fate Therapeutics